Medication info

Zadiempa Tablet 10 mg (Empagliflozin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Empagliflozin›10mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Light yellow, biconvex, round film-coated tablet
Packaging
10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202102091 · Approved 2021.03.05

This product's status changed to Approval withdrawn on 2025.04.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4. General Precautions).

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty controlling blood sugar
  • inability to control blood sugar
  • cardiovascular disease
View approved original text

This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in adult patients with type 2 diabetes. It can be used as monotherapy and is sometimes combined with metformin or other diabetes medications to enhance blood sugar control. This medication is administered in cases where patients have not previously received diabetes medication treatment or when sufficient blood sugar control is difficult with monotherapy. Additionally, it can also be used in patients who struggle to achieve control with insulin or various combination therapies. For patients with cardiovascular diseases, it is essential to confirm any precautions prior to use. Overall, this medication aids in diabetes management by improving blood sugar control.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4. General Precautions).

Precautions

This medication should not be used by patients who are allergic to the active ingredient or other components of this medication. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired renal function, end-stage renal disease, or those undergoing dialysis should not use this drug. Patients with genetic lactose intolerance should also avoid this medication due to the lactose it contains. For patients with mildly impaired renal function, dosage adjustment is necessary, and it should be discontinued if renal function is severely compromised. It is not expected to be effective in end-stage renal disease or those undergoing dialysis. Regular monitoring of renal function before and during treatment with this medication is recommended. Caution is advised for patients with mild to moderate heart failure, and its use is not recommended for patients with severe heart failure. When used in conjunction with insulin or sulfonylureas, there may be a risk of hypoglycemia, requiring potential dosage adjustments of those medications. Use of this medication may result in hypoglycemia, genital infections, increased urination, urinary tract infections, decreased blood volume, increased serum creatinine, etc. Hypoglycemia may occur more frequently when combined with insulin or sulfonylureas, so caution is advised. This medication can cause severe ketoacidosis; therefore, if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur, consult a healthcare provider immediately. In elderly patients, particularly those over 75, the risk of fluid loss is increased, so careful observation is necessary, and it is not recommended for those over 85. This medication may increase the risk of dehydration, hypotension, urosepsis, pyelonephritis, and fungal infections of the genital area, so prompt treatment is required if any infection symptoms appear. While taking this medication, glucose may be detected in urine tests, and caution should be taken to avoid hypoglycemia when driving or operating machinery. Long-term use may increase the risk of limb amputation, so foot care is crucial, and if pain or swelling in the perineum occurs, healthcare personnel should be informed immediately. It is advisable not to use this medication during pregnancy, and use should be discontinued if pregnancy is confirmed. During breastfeeding, it is recommended to stop breastfeeding as this medication may secret into breast milk. Safety and efficacy have not been established in pediatric patients under 18 years of age, so the medication should not be used in this population. No specific toxic reactions have been reported in case of overdose; however, appropriate treatment may be necessary depending on clinical status. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvovaginitis
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • pruritus
  • rash
  • urticaria
Show 226 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • urinary difficulties
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • traction retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasms of the ampulla of Vater
  • benign ovarian tumors
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • cavities
  • gastric ulcer
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • blood in stool
  • hemorrhoids
  • colonic hemorrhage
  • pancreatic cysts
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • paronychia
  • tinea corporis
  • dental abscess
  • nasopharyngitis
  • positional vertigo
  • sensory loss
  • perceptual anomalies
  • amnesia
  • carotid stenosis
  • diabetic neuropathy
  • facial paralysis
  • memory disorders
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory disturbances
  • drowsiness
  • CNS origin dizziness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • odd sensations
  • edema
  • pain
  • pain at injection site
  • weight gain
  • abnormal ECG
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary erythrocytes
  • chronic kidney disease
  • hematuria
  • overactive bladder
  • renal masses
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • dyslipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataracts
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival hyperemia
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • moist cough
  • allergic rhinitis
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral arterial obstructive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodules
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes mellitus
  • diabetic retinopathy
  • dry eyes
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is also important to avoid extremely hot or cold places and maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, biconvex, round film-coated tablet

Package unit

10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.